Small Airway Dysfunction in Chronic Obstructive Pulmonary Disease Pathology: Assessment and Clinical Implications.

Area of Science:

• Pulmonary Medicine
• Respiratory Research
• Pathophysiology

Background:

• Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease defined by airflow limitation.
• Small Airway Dysfunction (SAD), affecting airways <2mm, is a key driver of COPD progression.
• Inflammatory remodeling and obstruction in small airways precede spirometric changes in COPD.

Purpose of the Study:

• To review the role of SAD in COPD pathophysiology.
• To discuss the clinical implications of SAD measurements.
• To explore potential treatment strategies for SAD in COPD.

Main Methods:

• Review of current literature on SAD in COPD.
• Analysis of measurement techniques including pulmonary function tests (e.g., FEF25-75%) and CT imaging (e.g., PRM).
• Discussion of clinical manifestations like gas trapping and hyperinflation.

Main Results:

• SAD increases airway resistance and promotes dynamic airway collapse.
• SAD correlates with accelerated lung function decline and exercise intolerance.
• SAD is a potentially modifiable trait in COPD management.

Conclusions:

• SAD is a critical component of COPD pathophysiology with significant clinical impact.
• Accessible measurements like FEF25-75% and PRM can assess SAD.
• Management strategies targeting SAD, including inhalers and rehabilitation, are crucial for COPD patients.